Role of DPP 4 Inhibitors (Gliptins) in Diabetes Patients
Dipeptidyl peptidase 4 (DPP-4) inhibitors are a group of oral hypoglycemic agents used to manage Type 2 Diabetes Mellitus, which is a significant risk factor for coronary disease, heart failure, stroke, and many other cardiovascular conditions. DPP-4 inhibitors, known as gliptins, are a class of oral diabetic medications to treat type 2 diabetes mellitus in adults. DPP-4 inhibitors include sitagliptin,…